TG and differentiated thyroid carcinoma: In patients with differentiated thyroid cancer (DTC), stimulated serum thyroglobulin (Tg) concentration measured around the time of radioiodine (RAI) treatment is a valuable prognostic factor for persistent/recurrent disease [1–5].